Genoskin raises $8.7M in Series A funding led by OCCTE to drive growth and expand its commercial presence.
Amount Raised
$8.7 Million
Round Type
Series A
Investors
Description
Genoskin, a Toulouse-based CRO, raised $8.7M in Series A funding. The round included a $5.4M equity investment led by OCCTE and $3.3M in structured bank debt from Bpifrance and local partners. The funds will support growth and staff recruitment over the next three years. Genoskin specializes in improving drug testing with ex vivo human skin platforms.
Quick answer
Genoskin raised $8.7 Million in a Series A round, dated September 16, 2025. Investors: Captech Santé, Crédit Agricole, Caisse D’epargne Midi Pyrénées, BNP Paribas, Gso Innovation, Ca Toulouse 31 Initiatives, Bpifrance and Occte.
- How much did Genoskin raise?
- Genoskin raised $8.7 Million in a Series A round on September 16, 2025.
- Who invested in Genoskin?
- Captech Santé, Crédit Agricole, Caisse D’epargne Midi Pyrénées, BNP Paribas, Gso Innovation, Ca Toulouse 31 Initiatives, Bpifrance and Occte are named as investors in this round.
- What does Genoskin do?
- Genoskin offers unmatched expertise in skin biology and immunology to support your research and drug development.
- Where is Genoskin based and how big is it?
- Fundz records about 46 employees.
- Who are the decision-makers at Genoskin?
- Fundz holds 1 contact at Genoskin. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Genoskin that raised within 45 days of this round, from Fundz verified event records.
- Sernova raised $345K (Seed) on October 31, 2025.
- Intensity Therapeutics raised $4M (Post-IPO Equity) on October 31, 2025.
- Creative Medical Technology Holdings raised $4.2M (Funding Round) on October 31, 2025.
- Zetagen Therapeutics raised $13M on October 31, 2025.
- Prelude raised $5M on October 30, 2025.
- Surgical Automations raised $3.4M (Seed) on October 30, 2025.
Who to call at Genoskin, and when
A new round usually means Genoskin is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Genoskin raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Genoskin, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Genoskin. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Genoskin raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGenoskin raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.